These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16674923)

  • 1. A novel single step double positive double negative selection strategy for beta-globin gene replacement.
    Khanahmad H; Noori Daloii MR; Shokrgozar MA; Azadmanesh K; Niavarani AR; Karimi M; Rabbani B; Khalili M; Bagheri R; Maryami F; Zeinali S
    Biochem Biophys Res Commun; 2006 Jun; 345(1):14-20. PubMed ID: 16674923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress toward the genetic treatment of the beta-thalassemias.
    Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
    Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy.
    Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y
    Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease.
    Sadelain M; Rivella S; Lisowski L; Samakoglu S; Rivière I
    Best Pract Res Clin Haematol; 2004 Sep; 17(3):517-34. PubMed ID: 15498721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific transfer of an intact beta-globin gene cluster through a new targeting vector.
    Zhou HS; Zhao N; Li L; Dong WJ; Wu XS; Hao DL; Guo ZC; Xia K; Xia JH; Liu DP; Liang CC
    Biochem Biophys Res Commun; 2007 Apr; 356(1):32-7. PubMed ID: 17339031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
    Sadelain M
    Curr Opin Hematol; 2006 May; 13(3):142-8. PubMed ID: 16567956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards β-globin gene-targeting with integrase-defective lentiviral vectors.
    Inanlou DN; Yakhchali B; Khanahmad H; Gardaneh M; Movassagh H; Cohan RA; Ardestani MS; Mahdian R; Zeinali S
    Biotechnol Lett; 2010 Nov; 32(11):1615-21. PubMed ID: 20640481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The ht-PAm cDNA knock-in the goat beta-casein gene locus].
    Shen W; Yang ZT; Tian LY; Wu XJ; Chen H; Huang PT; Deng JX
    Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):361-5. PubMed ID: 15971606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro expression of beta-thalassaemia gene (IVS1-1G>C) reveals complete inactivation of the normal 5' splice site and alternative aberrant RNA splicing.
    Fujihara N; Yamauchi K; Hirota-Kawadobora M; Ishikawa S; Tozuka M; Ishii E; Katsuyama T; Okumura N; Taniguchi S
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):573-8. PubMed ID: 17961316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects for correction of thalassemia by genetic engineering.
    Gale RP
    Prog Clin Biol Res; 1989; 309():141-59. PubMed ID: 2571166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Third strand-mediated psoralen-induced correction of the sickle cell mutation on a plasmid transfected into COS-7 cells.
    Varganov Y; Amosova O; Fresco JR
    Gene Ther; 2007 Jan; 14(2):173-9. PubMed ID: 16943853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia.
    Bank A; Dorazio R; Leboulch P
    Ann N Y Acad Sci; 2005; 1054():308-16. PubMed ID: 16339679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of globin gene therapy for the treatment of beta-thalassaemia.
    Lisowski L; Sadelain M
    Br J Haematol; 2008 May; 141(3):335-45. PubMed ID: 18410569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of beta-globin gene mutations in Malaysian children: a strategy for the control of beta-thalassaemia in a developing country.
    Thong MK; Tan JA; Tan KL; Yap SF
    J Trop Pediatr; 2005 Dec; 51(6):328-33. PubMed ID: 15967770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted correction of the point mutations of beta-thalassemia and targeted mutagenesis of the nucleotide associated with HPFH by RNA/DNA oligonucleotides: potential for beta-thalassemia gene therapy.
    Li ZH; Liu DP; Yin WX; Guo ZC; Liang CC
    Blood Cells Mol Dis; 2001; 27(2):530-8. PubMed ID: 11500064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for the hemoglobin disorders.
    Persons DA; Nienhuis AW
    Curr Hematol Rep; 2003 Jul; 2(4):348-55. PubMed ID: 12901333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of SFHR to gene therapy of monogenic disorders.
    Goncz KK; Prokopishyn NL; Chow BL; Davis BR; Gruenert DC
    Gene Ther; 2002 Jun; 9(11):691-4. PubMed ID: 12032689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for hemoglobinopathies: are we there yet?
    Puthenveetil G; Malik P
    Curr Hematol Rep; 2004 Jul; 3(4):298-305. PubMed ID: 15217560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational spectrum of delta-globin gene in the Portuguese population.
    Morgado A; Picanço I; Gomes S; Miranda A; Coucelo M; Seuanes F; Seixas MT; Romão L; Faustino P
    Eur J Haematol; 2007 Nov; 79(5):422-8. PubMed ID: 17916081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient modification of human chromosomal alleles using recombination-proficient chicken/human microcell hybrids.
    Dieken ES; Epner EM; Fiering S; Fournier RE; Groudine M
    Nat Genet; 1996 Feb; 12(2):174-82. PubMed ID: 8563756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.